RF
AZN icon

Rossby Financial’s AstraZeneca AZN Stock Holding History

Rossby Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
1,904
-148
-7% -$27.8K 0.07% 257
2026
Q1 		$412K Buy
2,052
+463
+29% +$89.3K 0.08% 221
2025
Q4 		$292K Buy
1,589
+6
+0.4% +$1.05K 0.09% 200
2025
Q3 		$267K Buy
1,583
+21
+1% +$3.18K 0.09% 226
2025
Q2 		$218K Sell
1,562
-3
-0.2% -$420 0.08% 239
2025
Q1 		$218K Sell
1,565
-67
-4% -$9.69K 0.09% 210
2024
Q4 		$214K Buy
+1,632
New +$228K 0.13% 175

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rossby Financial's AZN Position: Q2 2026 in Review

Rossby Financial reduced its AstraZeneca (AZN) stake by 7.2% in Q2 2026, selling an estimated $27.8K and leaving 1,904 shares worth $361K. The position accounts for 0.07% of the portfolio, ranked #257.

Rossby Financial first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $412K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Rossby Financial held 1,904 shares of AstraZeneca worth $361K as of Q2 2026.
  • Rossby Financial sold 148 AstraZeneca shares in Q2 2026, an estimated $27.8K.
  • AstraZeneca made up 0.07% of Rossby Financial's portfolio in Q2 2026, its #257 holding.
  • Rossby Financial first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Rossby Financial's AstraZeneca position peaked at $412K in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.